London, United Kingdom

Bram Snijders

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Enara Bio Limited, The Francis Crick Institute Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bram Snijders. Retrieved from https://idiyas.com/inventor/bram-snijders

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bram Snijders: Innovator in Cancer Research

Introduction

Bram Snijders is a notable inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly in the development of cancer antigens and methods for their application in treatment and diagnosis.

Latest Patents

Bram Snijders holds a patent related to cancer antigens. This patent includes polypeptides and nucleic acids encoding these polypeptides, which are useful in the treatment, prevention, and diagnosis of cancer, especially melanoma, including cutaneous melanoma and uveal melanoma. He has 1 patent to his name.

Career Highlights

Throughout his career, Bram has worked with prominent organizations in the field of biomedical research. Notably, he has been associated with The Francis Crick Institute Limited and Enara Bio Limited, where he has contributed to groundbreaking research and innovation.

Collaborations

Bram has collaborated with esteemed colleagues, including George Kassiotis and George Young, further enhancing the impact of his work in cancer research.

Conclusion

Bram Snijders is a dedicated inventor whose work in cancer antigens has the potential to significantly advance the treatment and diagnosis of melanoma. His contributions to the field are invaluable and reflect his commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…